Disbrow Joshua R. 4
4 · AYTU BIOPHARMA, INC · Filed Jun 10, 2025
Insider Transaction Report
Form 4
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Purchase
Common Stock
2025-06-09$1.50/sh+66,666$99,999→ 153,257 total
Footnotes (1)
- [F1]Purchased pursuant to the Issuer's registered offering more particularly described on the Registration Statement on Form S-1, as amended, filed by the Issuer on June 2, 2025.